Canakinumab Subcutaneous and Oxymetazoline ophthalmic
Determining the interaction of Canakinumab Subcutaneous and Oxymetazoline ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: oxymetazoline ophthalmic
Brand name: Visine LR, Visine Long Lasting, Ocuclear
Synonyms: Oxymetazoline (Ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Oxymetazoline topical
- Canakinumab Subcutaneous-Oxymetazoline Topical application
- Canakinumab Subcutaneous-Oxymetholone
- Canakinumab Subcutaneous-Oxymorphone
- Canakinumab Subcutaneous-Oxymorphone Extended-Release Tablets
- Canakinumab Subcutaneous-Oxymorphone Hydrochloride
- Oxymetazoline ophthalmic-Canasa
- Oxymetazoline ophthalmic-Canasa Pac rectal
- Oxymetazoline ophthalmic-Canasa rectal
- Oxymetazoline ophthalmic-Cancidas
- Oxymetazoline ophthalmic-Candesartan
- Oxymetazoline ophthalmic-Candesartan and Hydrochlorothiazide